Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

The genetic basis for smoking behavior: a systematic review and meta-analysis.

Munafò M, Clark T, Johnstone E, Murphy M, Walton R.

Nicotine Tob Res. 2004 Aug;6(4):583-97. Review.

PMID:
15370155
2.

'Smoking genes': a genetic association study.

Verde Z, Santiago C, Rodríguez González-Moro JM, de Lucas Ramos P, López Martín S, Bandrés F, Lucia A, Gómez-Gallego F.

PLoS One. 2011;6(10):e26668. doi: 10.1371/journal.pone.0026668. Epub 2011 Oct 26.

3.

Replication validity of genetic association studies of smoking behavior: what can meta-analytic techniques offer?

Munafò M.

Nicotine Tob Res. 2004 Apr;6(2):381-2. No abstract available.

PMID:
15203812
4.

Genetic influences on smoking: a brief review.

Al Koudsi N, Tyndale RF.

Ther Drug Monit. 2005 Dec;27(6):704-9. Review.

PMID:
16404798
5.

The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population.

Johnstone EC, Yudkin P, Griffiths SE, Fuller A, Murphy M, Walton R.

Addict Biol. 2004 Sep-Dec;9(3-4):221-6.

PMID:
15511716
6.

Association between dopamine receptor 2 TaqIA polymorphisms and smoking behavior with an influence of ethnicity: a systematic review and meta-analysis update.

Ohmoto M, Sakaishi K, Hama A, Morita A, Nomura M, Mitsumoto Y.

Nicotine Tob Res. 2013 Mar;15(3):633-42. doi: 10.1093/ntr/nts196. Epub 2012 Sep 18. Review.

PMID:
22990224
7.

The influence of genetics on nicotine dependence and the role of pharmacogenetics in treating the smoking habit.

Chatkin JM.

J Bras Pneumol. 2006 Nov-Dec;32(6):573-9. Review. English, Portuguese.

8.

Lack of association between DRD2 Taq1A gene polymorphism and smoking cessation therapy: a meta-analysis.

Choi HD, Shin WG.

Int J Clin Pharmacol Ther. 2015 Jun;53(6):415-21. doi: 10.5414/CP202214. Review.

PMID:
25881752
9.

Genetic epidemiology of smoking behavior and nicotine dependence.

Kaprio J.

COPD. 2009 Aug;6(4):304-6. Review.

PMID:
19811391
10.

Association of CYP2A6 gene polymorphisms with cigarette consumption: a meta-analysis.

Pan L, Yang X, Li S, Jia C.

Drug Alcohol Depend. 2015 Apr 1;149:268-71. doi: 10.1016/j.drugalcdep.2015.01.032. Epub 2015 Feb 7.

PMID:
25683822
11.

No relation between angiotensin-converting enzyme gene polymorphism and smoking dependence.

Hubacek JA, Adamkova V, Skodova Z, Lanska V, Poledne R.

Scand J Clin Lab Invest. 2004;64(6):575-8.

PMID:
15370463
12.

[Association between nicotine dependence and the -521 promoter polymorfism of the dopamine D4 receptor in patients with major depression].

Kótyuk E, Kovács-Nagy R, Faludi G, Urbán R, Rónai Z, Sasvári-Székely M, Székely A.

Neuropsychopharmacol Hung. 2009 Jun;11(2):59-67. Hungarian.

13.

A family smoking index to capture genetic influence in smoking: rationale and two validation studies.

Drobes DJ, Munafò MR, Leigh F, Saladin ME.

Nicotine Tob Res. 2005 Feb;7(1):41-6.

PMID:
15804676
14.
15.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

16.

Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis.

Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR.

Arch Intern Med. 2007 Feb 26;167(4):335-42. Review.

PMID:
17325294
17.

Personality and smoking status: a meta-analysis.

Munafò MR, Zetteler JI, Clark TG.

Nicotine Tob Res. 2007 Mar;9(3):405-13. Review.

PMID:
17365772
18.

Genes and cigarette smoking.

Munafò MR, Johnstone EC.

Addiction. 2008 Jun;103(6):893-904. doi: 10.1111/j.1360-0443.2007.02071.x. Epub 2008 Jan 8. Review.

PMID:
18190672
19.

'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.

Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D.

Health Technol Assess. 2008 Feb;12(2):iii-iv, ix-xi, 1-135. Review.

20.

Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions.

Bakker PR, van Harten PN, van Os J.

Mol Psychiatry. 2008 May;13(5):544-56. doi: 10.1038/sj.mp.4002142. Epub 2008 Jan 8.

PMID:
18180754

Supplemental Content

Support Center